Clinical Trial Detail

NCT ID NCT03426605
Title A Study of LAM-003 in Patients With Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Lam Therapeutics Inc.
Indications

acute myeloid leukemia

Therapies

LAM-003

Age Groups: adult senior

No variant requirements are available.